Stocks to Watch: Lucira Health, Tegna

By Sabela Ojea

Lucira Health Inc. on Friday received the U.S. Food and Drug Administration's emergency use authorization for its Covid-19 and Flu diagnostic test. Shares of the company, which provides at-home molecular tests and tele-health services for Covid-19, jumped 180% in after-hours trading.

Tegna Inc.'s $5.4 billion proposed sale to hedge fund Standard General L.P. will be further examined by an administrative law judge, the U.S. Federal Communications Commission said. Shares of the TV broadcaster dropped 26% in after-hours trading.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

February 24, 2023 18:43 ET (23:43 GMT)

Lucira Health (NASDAQ:LHDX)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024